|
Liver Degenerative
Disease
References
AMA. The American Medical Association Encyclopedia of
Medicine 1989. New York: Random House.
Anon. Holistic Health Encyclopedia 2002. Oakford, PA:
Telstar Innovations.
Attri, S., Rana, S.V., Vaiphie, K., Katyal, R., Sodhi,
C.P., Kanwar, S., Singh, K. Protective effect of
N-acetylcysteine in isoniazid induced hepatic injury in
growing rats. Indian J. Exp. Biol. 2001 May; 39(5):
436-40.
Bergasa, N.V. Itching in Liver Disease 2002 Sep; New York:
Columbia University.
Berson, A., De Beco, V., Letteron, P., Robin, M.A., Moreau,
C., El Kahwaji, J., Verthier, N., Feldmann, G., Fromenty, B.,
Pessayre, D. Steatohepatitis-inducing drugs cause
mitochondrial dysfunction and lipid peroxidation in rat
hepatocytes. Gastroenterology 1998 Apr; 114(4): 764-74.
Biewenga, G.P., Haenen, G.R., Bast, A. The pharmacology of
the antioxidant lipoic acid. Gen. Pharmacol. 1997 Sep; 29(3):
315-31.
Bosisio, E., Benelli, C., Pirola, O. Effect of the
flavanolignans of Silybum marianum L. on lipid peroxidation in
rat liver microsomes and freshly isolated hepatocytes.
Pharmacol. Res. 1992 Feb-Mar; 25(2): 147-54.
Braillon, A., Capron, J.P., Herve, M.A., Degott, C.,
Quenum, C. Liver in obesity. Gut 1985 Feb; 26(2): 133-9
Brewer, G.J., Fink, J.K., Hedera, P. Diagnosis and
treatment of Wilson's disease. Semin. Neurol. 1999; 19(3):
261-70.
Britton, R.S., Bacon, B.R. Role of free radicals in liver
diseases and hepatic fibrosis. Hepatogastroenterology 1994
Aug; 41(4): 34-8.
Chalasani, N., Gitlin, N. Severe recurrent hepatic
encephalopathy that responded to oral branched chain amino
acids. Am. J. Gastroenterol. 1996 Jun; 91(6): 1266-8.
Chern, C.L., Huang, R.F., Chen, Y.H., Cheng, J.T., Liu,
T.Z. Folate deficiency-induced oxidative stress and apoptosis
are mediated via homocysteine-dependent overproduction of
hydrogen peroxide and enhanced activation of NF-kappaB in
human Hep G2 cells. Biomed. Pharmacother. 2001 Oct; 55(8):
434-42
Day, C.P., Yeaman, S.J. The biochemistry of alcohol-induced
fatty liver. Biochem. Biophys. Acta 1994 Nov 17; 1215(1-2):
33-48.
Deulofeu, R., Pares, A., Rubio, M., Gasso, M., Roman, J.,
Gimenez, A., Varela-Moreiras, G., Caballeria, J., Ballesta,
A.M., Mato, J.M., Rodes, J. S-Adenosylmethionine prevents
hepatic tocopherol depletion in carbon tetrachloride-injured
rats. Clin. Sci. 2000 Oct; 99(4): 315-20.
Feher, J., Vereckei, A., Lengyel, G. Role of free-radical
reactions in liver diseases. Acta Physiol. Hung. 1992;
80(1-4): 351-61.
Fernandez, E., Pallini, R., Lauretti, L., La Marca, F.,
Sccgna, A., Rossi, G.F. Motonuclear changes after cranial
nerve injury and regeneration. Arch. Ital. Biol. 1997 Sep;
135(4): 343-51.
Garg, M.C., Bansal, D.D. Protective antioxidant effect of
vitamins C and E in streptozotocin induced diabetic rats.
Indian J. Exp. Biol. 2000 Feb; 38(2): 101-4.
Genova, M.L., Bonacorsi, E., D'Aurelio, M., Formiggini, G.,
Nardo, B., Cuccomarino, S., Turi, P., Pich, M.M., Lenaz, G.,
Bovina, C. Protective effect of exogenous coenzyme Q in rats
subjected to partial hepatic ischemia and reperfusion.
Biofactors 1999; 9(2-4): 345-9.
Glanze, W.D., Ed. Mosby Medical Encyclopedia, Revised
Edition 1996. St. Louis, MO: C.V. Mosby.
Gumina, G., Song, G.Y., Chu, C.K. Advances in antiviral
agents for hepatitis B virus. Antivir. Chem. Chemother. 2001;
12(Suppl. 1): 93-117.
Hazai, E., Monostory, K., Bakos, A., Zacher, G., Vereczkey,
L. About paracetamol again. Orv. Hetil. 2001 Feb 18; 142(7):
345-9 (in Hungarian).
Kato, M., Miwa, Y., Tajika, M., Hiraoka, T., Muto, Y.,
Moriwaki, H. Preferential use of branched-chain amino acids as
an energy substrate in patients with liver cirrhosis. Intern.
Med. 1998 May; 37(5): 429-34.
Khanna, S., Atalay, M., Laaksonen, D.E. et al. Alpha-lipoic
acid supplementation: tissue glutathione homeostasis at rest
and after exercise. J. Appl. Physiol. 1999 Apr; 86(4):
1191-6.
Lammert, F., Busch, N., Matern, S. Clinical aspects and
therapy of viral hepatitis. Chirug 2000 Apr; 71(4): 381-8 (in
German).
Lieber, C.S. Prevention and treatment of liver fibrosis
based on pathogenesis. Alcohol Clin. Exp. Res. 1999 May;
23(5): 944-9.
Lykkesfeld, J. et al. Age-associated decline in ascorbic
acid concentration, recycling, and biosynthesis in rat
hepatocytes-reversal with R alpha lipoic acid supplementation.
FASEB J. 1998; 12: 1183-9.
Ma, X., Zhao, J., Lieber, C.S. Polyenylphosphatidylcholine
attenuates non-alcoholic hepatic fibrosis and accelerates its
regression. J. Hepatol. 1996 May; 24(5): 604-13.
Malik, A.H., Lee, W.M. Chronic hepatitis B virus infection:
treatment strategies for the next millennium. Ann. Intern.
Med. 2000 May 2; 132(9): 723-31.
Mayerat, C., Mantegani, A., Spertini, F., Frei, P.C.
Mutations in the basal core promoter and precore/core gene of
hepatitis B virus in patients with chronic active but not
acute hepatitis B. Eur. J. Clin. Microbiol. Infect. Dis. 1999
Dec; 18(12): 871-8.
Mirossay, L., Mojzis, J., Sallingova, Z. et al.
Gastroprotective effect of malotilate in indomethacin- and
ethanol-induced gastric mucosal damage. Physiol. Res. 1996;
45(5): 405-11.
Mydlik, M., Derzsiova, K., Racz, O., Sipulova, A.,
Boldizsar, J., Lovasova, E., Hribikova, M. Vitamin E as an
antioxidant agent in CAPD patients. Int. J. Artif. Organs 2002
May; 25(5): 373-8.
Navder, K.P., Baraona, E., Lieber, C.S.
Polyenylphosphatidylcholine attenuates alcohol-induced fatty
liver and hyperlipemia in rats. J. Nutr. 1997 Sep; 127(9):
1800-6.
NIDA. Hepatitis C. NIDA Community Drug Alert Bulletin 2002
Feb 21. Bethesda, MD: National Institute on Drug
Abuse/National Institutes of Health/Department of Health and
Human Services.
NIDDK. Cirrhosis of the Liver 2000 Jan. NIH Publ. No.
00-1134. Bethesda, MD: National Institute of Diabetes and
Digestive and Kidney Diseases/National Institutes of
Health.
Nidus. What are the primary treatments for cirrhosis?
Well-Connected Report: Cirrhosis 1999 Mar. New York: Nidus
Information Services (www.well-connected.com).
Ou, J.H.J. Viral hepatitis and its prevention. Infection
Control Today Magazine 2002. Phoenix, AZ: Virgo
Publishing.
Paradies, G., Petrosillo, G., Gadaleta, M.N., Ruggiero,
F.M. The effect of aging and acetyl-L-carnitine on the
pyruvate transport and oxidation in rat heart mitochondria.
FEBS Lett. 1999 Jul 9; 454(3): 207-9.
Pniachik, J., Baraona, E., Zhaoi, J., Lieber, C.S.
Dilinoleoylphosphatidylcholine decreases hepatic stellate cell
activation. J. Lab. Clin. Med. 1999 Apr; 133(4): 342-8.
Rao, K.V., Qureshi, I.A. Reduction in the MK-801 binding
sites of the NMDA sub-type of glutamate receptor in a mouse
model of congenital hyper-ammonemia: prevention by
acetyl-L-carnitine. Neuropharmacology 1999 Mar; 38(3):
383-94.
Ryhanen, L., Stenback, F., Ala-Kokko, L., Savolainen, E.R.
The effect of malotilate on type III and type IV collagen,
laminin and fibronectin metabolism in
dimethylnitrosamine-induced liver fibrosis in the rat. J.
Hepatol. 1996 Feb; 24(2): 238-45.
Sakaguchi, S., Iizuka, Y., Furusawa, S., Tanaka, Y.,
Takayanagi, M., Takayanagi, Y. Roles of selenium in
endotoxin-induced lipid peroxidation in the rats liver and in
nitric oxide production in J774A.1 cells. Toxicol. Lett. 200
Dec 20; 118(1-2): 69-77.
Shimazu, Y. An experimental and clinical study of
energy-protein metabolism and host defense-repair mechanism in
postoperative period-a significance of administration of
branched chain amino acid. Nippon Geka Gakkai Zasshi 1990 Oct;
91(10): 1534-47 (in Japanese).
Sonnenbichler, J., Goldberg, M., Hane, L., Madubunyi, I.,
Vogl, S., Zetl, I. Stimulatory effect of silibinin on the DNA
synthesis in partially hepatectomized rat livers: non-response
in hepatoma and other malign cell lines. Biochem. Pharmacol.
1986a Feb 1; 35(3): 538-41.
Sonnenbichler, J., Zetl, I. Biochemical effects of the
flavonolignane silibinin on RNA, protein and DNA synthesis in
rat livers. Prog. Clin. Biol. Res. 1986b; 213: 319-31.
Strickland, D.K. Hepatitis C. eMed. J. 2002 Jan 16
(http://www.emedicine.com/ped/topic979.htm).
Takase, S., Matsuda, Y., Yasuhara, M., Takada, A. Effects
of malotilate treatment on alcoholic liver disease. Alcohol
1989 May-Jun; 6(3): 219-22.
Teranishi, M., Karbowski, M., Kurono, C., Nishizawa, Y.,
Usukura, J., Soji, T., Wakabayashi, T. Effects of coenzyme Q10
on changes in the membrane potential and rate of generation of
reactive oxygen species in hydrazine- and
chloramphenicol-treated rat liver mitochondria. Arch. Biochem.
Biophys. 1999 Jun 1; 366(1): 157-67.
Valenzuela, A., Aspillaga, M., Vial, S., Guerra, R.
Selectivity of silymarin on the increase of the glutathione
content in different tissues of the rat. Planta Med. 1989 Oct;
55(5): 420-2.
Vineis, P., Esteve, J., Terracini, B. Bladder cancer and
smoking in males: types of cigarettes, age at start, effect of
stopping and interaction with occupation. Int. J. Cancer 1984
Aug 15; 34(2): 165-70.
Vineis, P., Magnani, C. Occupation and bladder cancer in
males: a case-control study. Int. J. Cancer 1985 May 15;
35(5): 599-606.
Wallace, L.A., Pellizzari, E.D., Hartwell, T.D., Davis, V.,
Michael, L.C., Whitmore, R.W. The influence of personal
activities on exposure to volatile organic compounds. Environ.
Res. 1989 Oct; 50(1): 37-55.
Wolf, D.C. Cirrhosis. eMed. J. 2001 Sep 6; 2(9)
(http://www.emedicine.com/med/topic3183.htm).
Yang, S.Q., Lin, H.Z., Lane, M.D., Clemens, M., Diehl, A.M.
Obesity increases sensitivity to endotoxin liver injury:
implications for the pathogenesis of steatohepatitis. Proc.
Natl. Acad. Sci. U.S.A. 1997 Mar 18; 94(6): 2557-62.
|